Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
LUMOS PHARMA, INC. (LUMO)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
6 Feb 2024
McKew John C.
Chief Scientific Officer, Officer
LUMOS PHARMA, INC.
((LUMO))
18,403
-2%
438
$3.03
$1,328.02
SELL
1 Aug 2023
McKew John C.
Chief Scientific Officer, Officer
LUMOS PHARMA, INC.
((LUMO))
18,707
-15%
3,407
$3.21
$10,919.44
SELL
1 Apr 2023
McKew John C.
Chief Scientific Officer, Officer
LUMOS PHARMA, INC.
((LUMO))
23,207
-8%
2,214
$3.27
$7,239.78
SELL
1 Feb 2023
McKew John C.
Chief Scientific Officer, Officer
LUMOS PHARMA, INC.
((LUMO))
26,457
-1%
439
$3.53
$1,549.67
BUY
16 Nov 2022
McCracken Joseph S
Director
LUMOS PHARMA, INC.
((LUMO))
15,721
+34%
4,000
$5.03
$20,120.00
BUY
21 Sep 2022
Hawkins Richard J
Chief Executive Officer, Director, Officer
LUMOS PHARMA, INC.
((LUMO))
4,469
+118%
2,422
$8.84
$21,402.16
BUY
19 Sep 2022
Hawkins Richard J
Chief Executive Officer, Director, Officer
LUMOS PHARMA, INC.
((LUMO))
2,047
+100%
2,047
$8.72
$17,857.15
SELL
1 Aug 2022
McKew John C.
Chief Scientific Officer, Officer
LUMOS PHARMA, INC.
((LUMO))
24,602
-12%
3,407
$8.11
$27,630.77
SELL
6 Jun 2022
McKew John C.
Chief Scientific Officer, Officer
LUMOS PHARMA, INC.
((LUMO))
29,102
-0%
169
$7.62
$1,287.78
SELL
1 Apr 2022
McKew John C.
Chief Scientific Officer, Officer
LUMOS PHARMA, INC.
((LUMO))
29,271
-7%
2,214
$8.32
$18,420.48
BUY
8 Sep 2021
LALANDE KEVIN M.
Director
LUMOS PHARMA, INC.
((LUMO))
730,446
+1%
10,000
$11.21
$112,116.00
SELL
8 Sep 2021
McKew John C.
Chief Scientific Officer, Officer
LUMOS PHARMA, INC.
((LUMO))
31,012
-6%
2,214
$11.30
$25,018.20
BUY
2 Sep 2021
LALANDE KEVIN M.
Director
LUMOS PHARMA, INC.
((LUMO))
720,446
+3%
24,400
$11.22
$273,782.94
BUY
30 Aug 2021
LALANDE KEVIN M.
Director
LUMOS PHARMA, INC.
((LUMO))
696,046
+2%
19,214
$10.66
$204,810.60
BUY
25 Aug 2021
LALANDE KEVIN M.
Director
LUMOS PHARMA, INC.
((LUMO))
677,832
+4%
26,081
$10.04
$261,789.75
BUY
20 Aug 2021
LALANDE KEVIN M.
Director
LUMOS PHARMA, INC.
((LUMO))
651,751
+14%
84,254
$9.21
$775,659.90
BUY
17 Aug 2021
LALANDE KEVIN M.
Director
LUMOS PHARMA, INC.
((LUMO))
567,497
+12%
64,870
$8.58
$556,425.50
BUY
12 Aug 2021
LALANDE KEVIN M.
Director
LUMOS PHARMA, INC.
((LUMO))
502,627
+22%
93,000
$7.79
$724,392.50
BUY
11 Aug 2021
McCracken Joseph S
Director
LUMOS PHARMA, INC.
((LUMO))
8,551
+694%
7,475
$7.55
$56,406.35
BUY
11 Aug 2021
Schuchart Aaron
Chief Business Officer, Officer
LUMOS PHARMA, INC.
((LUMO))
3,037
+192%
2,000
$7.41
$14,819.00
SELL
6 Jan 2021
Flynn James E
10% Owner, *Possible Member of 10% Group
LUMOS PHARMA, INC.
(LUMO)
890,080
-14%
151,723
$22.58
$3,425,623.20
SELL
10 Jul 2018
Talarico Ernest III
Director
NEWLINK GENETICS CORP
((NLNK))
32,223
-4%
1,534
$43.42
$66,600.14
SELL
21 Nov 2017
Langren Carl W.
Principal Accounting Officer, Officer
NEWLINK GENETICS CORP
((NLNK))
19,666
-1%
247.667
$81.45
$20,172.45
BUY
6 Oct 2017
Stine Seed Farm, Inc.
10% Owner
NEWLINK GENETICS CORP
((NLNK))
7,857,732
+1%
86,720.78
$92.25
$7,999,992.00
SELL
14 Dec 2016
Langren Carl W.
Principal Accounting Officer, Officer
NEWLINK GENETICS CORP
((NLNK))
10,691
-3%
438.111
$97.65
$42,781.55
BUY
6 Jun 2016
Talarico Ernest III
Director
NEWLINK GENETICS CORP
((NLNK))
32,223
+1%
451.667
$110.88
$50,080.80
SELL
7 Apr 2016
Link Charles J. Jr.
Chairman of the Board and CEO, Director, Officer
NEWLINK GENETICS CORP
((NLNK))
282,756
-0%
1,111.111
$180.22
$200,250.00
SELL
15 Mar 2016
Link Charles J. Jr.
Chairman of the Board and CEO, Director, Officer
NEWLINK GENETICS CORP
((NLNK))
297,756
-0%
2,777.778
$160.78
$446,600.00
SELL
3 Feb 2016
Link Charles J. Jr.
Chairman of the Board and CEO, Director, Officer
NEWLINK GENETICS CORP
((NLNK))
331,256
-0%
2,777.778
$217.45
$604,025.00
SELL
4 Jan 2016
HENNEMAN JOHN B III
EVP, Chief Financial Officer, Officer
NEWLINK GENETICS CORP
((NLNK))
62,316
-0%
19.444
$321.66
$6,254.50
SELL
4 Jan 2016
Langren Carl W.
Principal Accounting Officer, Officer
NEWLINK GENETICS CORP
((NLNK))
13,965
-0%
121.667
$314.77
$38,297.00
SELL
4 Jan 2016
Link Charles J. Jr.
Chairman of the Board and CEO, Director, Officer
NEWLINK GENETICS CORP
((NLNK))
350,656
-0%
3,333.445
$296.59
$988,672.90
SELL
4 Jan 2016
Wiley Brian
VP of Business Development, Officer
NEWLINK GENETICS CORP
((NLNK))
20,942
-0%
143.889
$314.87
$45,306.70
SELL
4 Jan 2016
Vahanian Nicholas N.
President, Chief Medical Offic, Officer
NEWLINK GENETICS CORP
((NLNK))
66,284
-0%
334.556
$315.50
$105,552.80
Home